Cannabis multistate operators with medical marijuana licenses in New York received the green light from state regulators Friday to enter the adult-use market on Dec. 29, exactly one year after the state launched recreational sales.
The Cannabis Control Board’s approval had been anticipated for months, but the decision marks a controversial milestone in the rollout of the state’s recreational marijuana market.
It follows the New York State Supreme Court’s Dec. 1 decision to lift an injunction that had prevented regulators from handing out new adult-use business licenses.
The CCB, at its meeting Friday, approved the following six registered organizations, New York’s version of MSOs:
Columbia Care NY, whose parent is New York-based MSO The Cannabist Co. Curaleaf NY, part of New York-headquartered MSO Curaleaf Holdings. Etain Health, owned by RIV Capital, a Toronto-based investment firm. NYCanna, part of New York-headquartered MSO Acreage Holdings. PharmaCann of
Read full article on Marijuana Business Daily